Microcalcifications in atherosclerotic plaques are destabilizing, predict adverse cardiovascular events, and are associated with increased morbidity and mortality.
F-fluoride positron emission tomography (PET)/computed tomography (CT) imaging has demonstrated promise as a useful clinical diagnostic tool in identifying high-risk plaques; however, there is confusion as to the underlying mechanism of signal amplification seen in PET-positive, CT-negative image regions. This study tested the hypothesis that 18 F-fluoride PET/CT can identify early microcalcifications.
METHODS:
18 F-fluoride signal amplification derived from microcalcifications was validated against near-infrared fluorescence molecular imaging and histology using an in vitro 3-dimensional hydrogel collagen platform, ex vivo human specimens, and a mouse model of atherosclerosis.
RESULTS:
Microcalcification size correlated inversely with collagen concentration. The Creager et al; PET Imaging of Atherosclerotic Microcalcification C oronary artery calcium is a common feature of atherosclerosis and quantification of coronary artery calcium from computed tomographic scans predicts adverse coronary heart disease events. [1] [2] [3] Coronary artery calcification is a pathophysiologic process that is intrinsic to the atherosclerotic plaque and is triggered by inflammation as calcifying extracellular vesicles (EVs) are released from macrophages and vascular smooth muscle cells. [4] [5] [6] [7] Large calcifications within the plaque form from microcalcifications and microcalcifications result from the aggregation and fusion of individual calcifying EVs. 6, 8 Whereas large calcifications may provide biomechanical stability, microcalcifications (<50 µm) that form within the fibrous cap intensify the incident stresses and can lead to microfractures and plaque rupture. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Indeed, microcalcification is apparent in high-risk atheroma, predicts adverse cardiovascular events, and is associated with increased morbidity and mortality. 4, 13, 17, [20] [21] [22] [23] [24] [25] [26] Computed tomography (CT) used in clinical applications has a resolution limit of ≈200 µm and, therefore, is not conducive to detecting microcalcifications. 18, 19, [27] [28] [29] [30] [31] Other imaging methods, such as intravascular ultrasound and optical coherence tomography, with resolution thresholds of 100 and 10 µm, respectively, can detect calcification but require invasive angiographic assessment. 8, 32 Therefore, noninvasive methods to identify microcalcification in atherosclerotic plaques are needed to detect high-risk patients and improve prevention and treatment of coronary artery disease. 9,13,33-35 18 F-fluoride positron emission tomography/CT (PET/ CT) is a sensitive and specific method for detecting microcalcification in high-risk atherosclerotic plaques ex vivo and, despite relatively poor spatial resolution, is a highly reproducible technique for detection of early coronary artery calcification in vivo. 4, 9, 21, [36] [37] [38] Furthermore, the spatial resolution of 18 F-fluoride PET/CT is adequate for localization to specific regions of atherosclerosis 9 ; it has been shown to identify high-risk and ruptured coronary plaques in patients with coronary artery disease. 32 PET/CT imaging has been shown to detect vulnerable atherosclerotic plaques, and regions that are PET-positive distal and proximal to advanced macrocalcifications. 9, 24, 37 It has been suggested that the positive signal seen in these regions is because of developing microcalcifications surrounding macrocalcifications. These regions of microcalcifications have previously been associated with high-PET and low-CT signals. Because PET imaging has poorer resolution than CT imaging, the increased PET signal may be because of signal amplification resulting from increased surface area and, consequently, more binding sites, on microcalcifications compared with larger calcifications. It has been suggested that the CT-negative, PET-positive signal observed adjacent to CT-positive regions is an artifact because of the partial-volume effect. 39 The goal of this study is to determine the specificity with which the 18 F-fluoride signal associates with microcalcifications and, furthermore, whether the PET signal is amplified because of increased surface area.
Because microcalcification detection lies below the resolution of current imaging modalities and, therefore, is difficult to monitor in vivo, we previously developed a 3-dimensional (3D) collagen hydrogel platform, which allows the growth of microcalcifications to be followed in vitro. 8 To determine if the increased PET signal is because of signal amplification resulting from microcalcifications, and address the lingering controversy in the field, this study utilized a controllable 3D hydrogel model of fibrous cap to simulate microcalcification growth, as well as comparative ex vivo analysis of calcified human atherosclerotic plaques and a mouse model of atherosclerosis.
METHODS
The data and study materials will be available to other researchers for purposes of reproducing the results or replicating the procedure.
The following experiments were conducted in accordance with Brigham 
CLINICAL PERSPECTIVE
Early microcalcification is associated with atherosclerotic plaque rupture in contrast to advanced later macrocalcification that potentially contributes to plaque stability. 18 F-fluoride positron emission tomography is believed to identify these regions of microcalcification. The objective of this article was to evaluate the mechanism of 18 F-fluoride binding in atherosclerotic plaque using an in vitro microcalcification model and ex vivo human tissue and to confirm feasibility for identification of atherosclerotic plaques with microcalcifications in an in vivo mouse model. 18 F-fluoride preferentially bound to the surface of nanocrystalline hydroxyapatite in regions that were remote from macrocalcific deposits. Moreover, the intensity of the 18 F-fluoride signal increased with smaller sized crystals of hydroxyapatite and was associated with histological markers of osteogenic activity. These novel mechanistic insights support 18 F-fluoride positron emission tomography as a marker of microcalcification and a means of identifying coronary and carotid plaques with an adverse morphology. Clinical trials are ongoing to assess the prognostic utility of 18 F-fluoride positron emission tomography imaging in patients at high risk of recurrent plaque rupture events. 
Calcium Affinity Study
To determine the affinity of calcium salts with markers of microcalcification, biologically relevant calcium salts found in atherosclerotic plaques were incubated with a near-infrared fluorescence (NIRF) molecular imaging agent, and the signals were quantified. Ten mg each of hydroxyapatite (289396-25G; Sigma-Aldrich), calcium phosphate (900205-50G; Sigma-Aldrich), calcium pyrophosphate (401552-25G; Sigma-Aldrich), calcium oxalate (455997-5G; Sigma-Aldrich), and calcium carbonate (C4830-100G; Sigma-Aldrich) were incubated with a NIRF calcium tracer (OsteoSense680, Perkin Elmer, NEV10020EX). The minerals were incubated with 1 mL of a 200-fold dilution of the stock solution for 1 hour at room temperature without light in a rotator. Subsequently, they were washed 3× with a 40-fold excess of PBS by centrifugation at 10 000g for 15 minutes, followed by removal of the supernatant and resuspension with PBS. Afterward, they were imaged by fluorescence microscopy on an Eclipse 80i microscope (Nikon, Melville, NY). Bright field and fluorescence images were taken and analyzed by thresholding for visible mineral crystals. Both values from bright field and fluorescence image analyses were matched per image taken to determine the fluorescence signal per amount of mineral.
An additional 10 mg of each of the minerals were incubated for 1 hour with 1 mL of 18 F-fluoride solution with an activity of 10 µCi/mL at room temperature without light in a rotator and afterward was washed 3× with a 40-fold excess of PBS. The radioactivity of the minerals was measured with a gamma well counter (Wizard2 Gamma Counter, Perkin Elmer), and the minerals were exposed overnight to a storage phosphor imaging plate for autoradiography.
In Vitro Microcalcification Model
Human coronary artery smooth muscle cells (PromoCell) passages 3 to 5 were grown to confluence and cultured in control media (DMEM with 10% FBS and 1% penicillin/streptomycin) and in procalcifying media consisting of control media with the addition of 10 nmol/L dexamethasone, 100 µmol/L L-ascorbic acid, and 10 mmol/L β-glycerophosphate. Media were replaced every 3 days. The culture media were replaced at 7, 14, and 21 days with media containing the same components, except that 0.1% FBS was used to reduce noise caused by EVs present in the serum. After 24 hours, the 0.1% FBS-media were collected and centrifuged for 5 minutes at 1000g to remove contaminants such as apoptotic bodies and cell debris. The resulting supernatant was stored at −80°C.
Collagen hydrogels for in vitro formation of microcalcifications were prepared by slowly increasing the pH of concentrated rat tail collagen stored in an acetic acid solution (BD Biosciences) to 7 to 8, thereby leading to formation of a collagen network. 8 The previously collected and concentrated EVs were then added to the hydrogels and incubated for 5 days. The hydrogels were incubated with a NIRF calcium tracer overnight and imaged by fluorescence and confocal microscopy. For PET tracer analysis, the hydrogels were incubated for 1 hour with a solution of 18 F-fluoride with an activity of 1 µCi/mL, washed 3× with PBS, and placed in reaction tubes. The activity was measured using a gamma well counter (Wizard2 Gamma Counter, Perkin Elmer).
F-Fluoride µPET-CT of Carotid Endarterectomy and Coronary Arteries Specimens
Carotid artery specimens (n=2) were obtained with ethical approval and informed consent from patients undergoing carotid endarterectomy (National Health Service West of Scotland Research Ethics Committee 12/WS/0227). Atherosclerotic sections of left main coronary arteries (n=2) were obtained with ethical approval and informed relative authorization from the next of kin from victims of sudden death at the time of autopsy (National Health Service South East Scotland Research Ethics Committee 14/ SS/1090). Tissue was immediately fresh frozen at −80°C. Thawed nondecalcified carotid artery and coronary artery specimens were incubated for 60 minutes in 18 F-fluoride 100 kBq/mL solution (10.5 MBq 18 F-NaF in 99.5 mLs 0.9% NaCl). Specimens were twice washed in 10 mLs 0.9% NaCl for 5 minutes to remove unbound 18 F-fluoride. Specimens were scanned using high-resolution µPET (1:5 coincidence mode) and CT (semi-circular full trajectory, maximum field of view, 480 projections, 50 kVp, 300 ms and 1:4 binning; Mediso nanoScan PET/CT, Mediso Medical Imaging Systems, Hungary). PET data were reconstructed using Mediso iterative Tera-Tomo 3D reconstruction algorithm using 4 iterations, 6 subsets, full detector model, normal regularization, spike filter on, voxel size 0·6 mm, and 400 to 600 keV energy window. µPET-CT images were analyzed on an OsiriX workstation (OsiriX version 7.5.1, 64-bit, OsiriX Imaging Software, Geneva, Switzerland). μPET and μCT were acquired sequentially in the same field of view with no distortion of the alignment, thus ensuring direct colocalization of PET and CT datasets. Routine quality control/quality assurance procedures are performed on the preclinical PET/CT system to ensure that coregistration is within an acceptable range set by the manufacturer.
Histological Analyses
Samples were embedded in optimal cutting temperature compound and stored at −20°C until use. Tissues were sectioned in areas that were PET-positive and CT-negative and cut into 6-µm thick sections for further analyses. NIRF calcium tracer was used in a 1:200 dilution in PBS and applied to the sections overnight and stored at 4°C. Additional stains were used to identify calcifications within the sections and to verify the results of the NIRF tracer. In addition, we used von Kossa Stain (American MasterTech, KTVKO) to detect calcification. The tissue sections were fixed with formalin, covered in 5% silver nitrate solution, and then placed under UV light for 1 hour. The slides were then rinsed with 5% sodium thiosulfate and stained with Nuclear Red Fast stain. Finally, we used the VECTOR Red Alkaline Phosphatase Substrate kit (SK-5100) to detect osteogenic activity and early microcalcifications. We mixed the reagents included in the kit with 5 mL of 100 mmol/L Tris-HCl (pH 8.5) buffer as described in the product protocol. We covered the sections with the solution for 1 hour, and then rinsed the slides in Tris-HCl (pH 8.5) buffer. The samples were then stained for nuclei using Harris hematoxylin.
F-Fluoride Autoradiography of Histological Sections
Tissue sections for autoradiography were washed in PBS and incubated for 1 hour in 18 F-fluoride solution with an activity of 1 µCi/mL. Subsequently, the sections were again washed with PBS, dried, and exposed to a charged phosphorous plate overnight. The plate was scanned afterward, and autoradiograms were compared with NIRF images of the same sections obtained using a Nikon A1 confocal microscope (Nikon). The image was divided into 4 quadrants, and the total signal per quadrant was determined for both autoradiography and NIRF using the mean intensity value per quadrant. Values of identical quadrants were matched, and correlation was determined using the Pearson method.
Arterial Calcification Mouse Model
Thirty-week-old LDLr (low-density lipoprotein receptor) −/− male mice (n=10) that had been fed an atherogenic highfat, high-cholesterol diet (21% fat and 1.25% cholesterol, Research Diets D12108C, New Brunswick, NJ), a model of vascular calcification, for 15 weeks were studied. Agematched wild-type C57BL/6 mice (n=5, Jackson Laboratory, Bar Harbor, ME) were used as controls. The Institutional Animal Care and Use committees at Beth Israel Deaconess Medical Center and at Brigham and Women's Hospital approved all animal procedures.
Mice were injected with a NIRF imaging agent (OsteoSense680, Perkin Elmer) 24 hours before aorta extraction. After euthanasia, aortas were perfused with saline, extracted, and imaged with a fluorescence reflectance imaging Kodak imager to determine the fluorescence signal. The aortas were then incubated for 1 hour in a solution of 18 F-fluoride with an activity of 10 µCi/mL. After washing 3× with PBS, activity was measured using the well counter. The aortas were dipped in deionized-H 2 O and mounted onto platforms before the PET/CT scanning took place. After overnight storage at 4 o , aortas were embedded in optimal cutting temperature compound for further histological analyses.
Statistical Analysis
Quantitative data are given as mean±SD. The number of independent experiments is indicated as n. Statistical packages within GraphPad Prism were used to determine data normality and variance estimation. Differences between control and compound fluorescence signals were evaluated using the Kruskal-Wallis test with Dunn multiple comparison test. The 2-way ANOVA analysis was used for determining statistical significance across labeling methods and collagen concentration. The Welch correction for t tests was used for nonmatching sample sizes. A linear Pearson correlation method was used for correlative analyses for NIRF versus 18 F-fluoride measurements. Considering the user-defined image quadrant as a random effect, we modeled the correlation between NIRF versus 18 F-fluoride for all quadrants combined (nlme; R package). For each quadrant separately, we also tested whether any given histological section was an influential outlier by performing a Jackknife resampling method (Data Supplement). 40 For a variance component analysis, we used the variance component analysis R package. P values of P<0.05 were considered significant.
RESULTS

NIRF Calcium Tracer and 18 F-Fluoride Show Preferential Affinity for Hydroxyapatite
The NIRF calcium tracer exhibited high affinity for hydroxyapatite when compared with calcium phosphate, calcium oxalate, and calcium carbonate ( Figure 1A) . The NIRF calcium tracer exhibited some affinity for pyrophosphate, but affinity was 85% less than that of the hydroxyapatite. Compared with hydroxyapatite, NIRF signal was reduced by 98.2% for calcium phosphate and 98.5% for calcium oxalate and calcium carbonate.
18 F-fluoride showed high affinity for hydroxyapatite at 13 Figure 1B ). 18 F-fluoride also showed decreased affinity for pyrophosphate by 36% at 8.91×10
5 CPM. Qualitative observations using fluorescence microscopy and autoradiography images ( Figure 1C and 1D ) support these quantification results, displaying the highest signal in the hydroxyapatite samples. The 18 F-fluoride autoradiogram also showed signal for the calcium pyrophosphate to a lesser degree than that of the hydroxyapatite. These findings suggest that both 18 F-fluoride and the NIRF calcium tracer exhibit preferential binding for hydroxyapatite.
In Vitro Microcalcification Model
To assess the specificity of the 18 F-fluoride signal in an in vitro collagen hydrogel model of microcalcification formation, we used a mixture of radioactively labeled 18 F-fluoride and unlabeled fluoride (Cold NaF) to test for nonspecific binding of the tracer to microcalcifications. Hydrogels incubated with 18 F-fluoride (hot NaF) exhibited significantly higher radioactive CPM compared with untreated control hydrogels and hydrogels incubated with the Cold NaF mixture (P=0.0014). Our previous work demonstrated that microcalcifications grown in vitro decrease in size as collagen concentration increases. 8 Similar to that study, smaller and more numerous microcalcifications were observed with a NIRF calcium tracer in hydrogels with higher collagen content ( Figure 2B ). Autoradiography images indicated increased 18 F-fluoride signal associated with the smaller microcalcifications in the collagen-rich hydrogels ( Figure 2C ). This suggests that an increase in the surface area of microcalcifications, because of an increase in the number of smaller microcalcifications (0.5 mg/mL collagen hydrogel), compared with fewer, larger microcalcifications (0.25 mg/mL collagen hydrogel), correlates with an increase in 18 F-fluoride PET signal.
PET/CT of Carotid Endarterectomy and Coronary Artery Specimens
Explanted carotid endarterectomy and coronary artery ( Figure 3A ) samples (n=4) were incubated in 100 kBq/ mL 18 F-fluoride and imaged using PET-CT. Fused PET/CT images of ex vivo coronary artery showed high 18 F-fluoride activity in areas of coronary artery without CTmacrocalcification ( Figure 3B , 3C, and 3D) with axial reconstruction confirming that binding colocalizes to discrete regions in the coronary artery wall ( Figure 3E ). 3D volume-rendered casts of ex vivo carotid endarterectomy specimens demonstrated 18 F-fluoride binding to the samples with ( Figure 3F , 3G, and 3I) and without macrocalcification ( Figure 3J , 3K, and 3L). Transverse view of PET/CT images confirmed 18 F-fluoride binding to the surface of exposed macrocalcified regions and noncalcified regions of the artery wall ( Figure 3H , 3I, 3K [inset] and Figure 3L [inset]). The discrete signal of 18 F-fluoride activity in noncalcified regions (PETpositive/CT-negative) suggests that 18 F-fluoride binding cannot be explained by the presence of macrocalcification alone. 
Histological Analyses of PET-Positive and CT-Negative Areas of Carotid Endarterectomy Samples
Staining of PET-positive and CT-negative regions of carotid endarterectomy samples with a NIRF calcium tracer revealed the presence of microcalcifications within the sections ( Figure 4A ). Autoradiography of consecutive sections after incubation with 18 F-fluoride showed similar patterns of intensity-rich areas ( Figure 4B and 4C) . The sections were visually aligned, and the images were divided into quadrants to compare the fluorescent and PET signal intensities ( Figure 4D) . A correlation analysis revealed a strong correlation between the fluorescence of the NIRF calcium tracer and 18 F-fluoride ( Figure 4E ; Pearson R=0.8048; P=0.0124). Figure 5B ). Micro-PET/CT scans of the aortas showed regions of high-PET signal that were comparable to signal-rich areas within the fluorescence images (Figure 5C ). To validate the detection of calcified areas with micro-PET/CT, histological analyses were performed on the aorta sections with high-PET signal and fluorescence. The results confirmed the presence of macroscale and microscale calcifications within the aorta, which correlate with fluorescence and PET imaging ( Figure 5C ).
Micro-PET/CT Scan of Calcified Murine Aortas
DISCUSSION
The salient new findings from this study are that regions identified as PET-positive and CT-negative with 18 F-fluoride PET/CT imaging are because of the presence of developing microcalcifications within atherosclerotic plaque. 18 F-fluoride and the NIRF molecular imaging showed preferentially high affinity for hydroxyapatite when compared with other biologically relevant calcium salts. The NIRF calcium tracer is already a well-established marker for cardiovascular calcification. Specifically, it has been demonstrated to visualize early microcalcifications in human samples and preclinical mouse models. 8, 31, 41, 42 Therefore, we used this NIRF tracer as a corroborative marker for comparison to 18 F-fluoride is a highly sensitive radiotracer that has been used in oncological practice to image bone tumors. 4, 9, 43 More recently, it has been found to exhibit uptake in atherosclerotic aorta and coronary arteries. 44, 45 Hydroxyapatite is a primary constituent of vascular calcification, 31 and the 18 F-fluoride ion is incorporated into the hydroxyapatite structure through an exchange of the hydroxyl groups on the surface of the mineral resulting in fluorapatite. 35,46,47 18 F-fluoride has favorable imaging properties as well, including minimal dissociation, tissue contrast between labeled, and unlabeled tissues 1 hour after administration, rapid binding, and low radiotracer background. 21 The calcific portions of atherosclerotic plaque absorb 18 F-fluoride selectively, with high affin- F-fluoride ligand binds to the surface of the calcification, and the increased surface area of microcalcifications allows for better absorption. 15 In contrast, there is proportionally smaller radioactivity signal detected for macrocalcifications. 1, 15, 45, 46 In this study, 18 F-fluoride demonstrated an affinity for cell-derived hydroxyapatite associated microcalcifications developed in vitro in a 3D collagen hydrogel system. When combined with unlabeled fluoride, 18 F-fluoride demonstrated specific binding for microcalcifications in the hydrogels. Additionally, the presence of these calcifications was confirmed with a NIRF calcium tracer, a current imaging standard in calcification cardiovascular research. These results suggest that the 18 F-fluoride tracer has the same affinity for organic hydroxyapatite produced by vascular smooth muscle cell-derived calcifying EVs. Our previous studies have demonstrated that hydrogels with a greater concentration of collagen have denser collagen networks and, therefore, limit the size to which microcalcifications can aggregate. 8 This results in an increase in the surface area of hydroxyapatite if the total amount of calcification remains the same. Smaller, more numerous microcalcifications form as the collagen concentration increases. It was found that higher concentrations of collagen displayed higher levels of 18 F-fluoride, suggesting that amplification in 18 F-fluoride signal is seen with the increased surface area.
In ex vivo carotid endarterectomy samples and coronary artery samples, an 18 F-fluoride PET signal is seen not just in areas of calcification, as identified by simultaneous CT imaging, but in noncalcified areas, both adjacent to and distal from calcifications. These results are consistent with those reported in earlier studies. 9, 21, 35, 48 The histological analyses of the areas with positive PET signal and negative CT signal revealed the presence of microcalcifications. This was first confirmed with the use of molecular imaging with NIRF calcium tracer, which is able to fluorescently tag microcalcifications. Adjacent tissue sections incubated with 18 F-fluoride displayed a similar pattern of signal, and a significant correlation was observed between both 18 F-fluoride and the NIRF signal. These findings suggest that the amplified PET signal that was observed in noncalcified areas of ex vivo sections was because of the presence of microcalcifications that were not detected by CT imaging. The amplification of the signal is likely because of the increased surface area of the microcalcifications.
Comparison of in vivo F-fluoride signal confirmed the presence of calcification. Alkaline phosphatase staining for early osteogenic activity and staining with NIRF calcium tracer both displayed relatively more signal when compared with von Kossa staining that detects phosphate groups in mature hydroxyapatite crystals. However, alkaline phosphatase and NIRF calcium stains are known to be more sensitive than von Kossa staining 31 and might indicate early-stage microcalcification. These findings suggest that 18 F-fluoride micro-PET/CT can identify microcalcifications in vivo and that the microcalcifications are the reason for PET signal amplification.
Notably, 18 F-fluoride uptake has been associated with patient populations with greater cardiovascular risk factor burden. 18 F-fluoride PET/CT detects microcalcification in patients with unstable manifestations of coronary atherosclerosis, 6, 10, 15, 32, 35 and patients with 18 F-fluoride uptake are more likely to have an increase in Framingham risk prediction scores, previous major adverse cardiac events, established coronary artery disease, angina, and revascularization. 9 The relatively low cost of the ligand and the excellent interobserver repeatability make it a strong candidate for clinical use. 35 Although it has been postulated that PET-positive regions extending beyond CT-positive regions can represent an artifact caused by partial-volume effects, 39 our study demonstrates that the 18 F-fluoride signal is associated with microcalcifications too small to be detected by CT imaging. The data show that the 18 F-fluoride ligand tags microcalcifications in a controllable 3D hydrogel model of fibrous cap progressively with increased surface area of microcalcifications and that these results can be translated to ex vivo analysis of human tissues, as well as mouse models of atherosclerosis. Our ex vivo incubation model may not exactly recreate in vivo conditions where 18 F-fluoride is delivered intravenously and where partial-volume effects may affect the coronary signal. Further work needs to be done to differentiate between false positives and false negatives in 18 F-fluoride PET/CT imaging; however, it is highly likely that 18 F-fluoride signal in PET-positive and CT-negative regions is because of the presence of microcalcifications. Additionally, further studies are required to determine if these results are possibly because of an increase in the surface area of the overall calcification. 18 F-fluoride PET/CT might have a role in evaluating patients with atherosclerotic disease, particularly by identifying areas of microcalcification in coronary arteries, implying the presence of vulnerable or recently ruptured plaques. Two ongoing clinical trials are using this radiotracer to assess whether 18 F-fluoride has prognostic utility in patients with myocardial in- farction (https://www.clinicaltrials.gov. Unique identifier: NCT02278211) and if 18 F-fluoride can be used to stratify patients to emerging therapeutic interventions (https://www.clinicaltrials.gov. Unique identifier: NCT02110303). This article adds to the growing body of knowledge that plaque mineralization is an active process and may be a target for clinical intervention. Early detection of unstable plaques could facilitate initiation and modulation of treatment to help prevent cardiovascular events. In conclusion, the findings of this study suggest that areas of microcalcification in developing atherosclerotic plaques are highly correlated with signal amplification of the
